Cost-effectiveness of mepolizumab for severe eosinophilic asthma in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of mepolizumab for severe eosinophilic asthma in China

Published:2024-03-12 Issue:9 Volume:61 Page:1068-1075
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Chaogang Xiong¹,Mengna An²,Zhen Wang³,Ying Li¹,Xin Gu¹,Xin Zhang¹,Shengjie Zhang¹,Yuan Zhao¹,Qian Lei¹,Wenbin Ma²,Weiyi Feng²

Affiliation:

1. Department of Pharmacy, Xi’an Chest Hospital, Xi’an, Shaanxi Province, China

2. Department of Pharmacy, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, China

3. Department of Pharmacy, Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi Province, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2024.2324855

Reference29 articles.

1. Examining Influenza Vaccination Patterns Among Young Adults with Asthma: Insights into Knowledge, Attitudes, and Practices

2. The prevalence of severe refractory asthma

3. The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma

4. Phenotype-Guided Asthma Therapy: An Alternative Approach to Guidelines

5. Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mepolizumab in Severe Pediatric Asthma: Certainties and Doubts through a Single-Center Experience and Review of the Literature;Children;2024-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3